Role of tumor necrosis factor alpha in asthma

Immunology and Allergy Clinics of North America

Volumn 24, Issue 4 SPEC. ISS., 2004, Pages 583-597

  Babu, K Suresh ^a   Davies, Donna E ^a   Holgate, Stephen T ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; ETANERCEPT; INFLIXIMAB; MACROGOL; MONOCLONAL ANTIBODY; PREDNISOLONE; SALBUTAMOL; THEOPHYLLINE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME INHIBITOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

AIRWAY OBSTRUCTION; ASTHMA; BRONCHUS HYPERREACTIVITY; CLINICAL TRIAL; CROHN DISEASE; DISEASE SEVERITY; HUMAN; IMMUNOBIOLOGY; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS;

EID: 4944250008     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iac.2004.06.010     Document Type: Review

References (88)

1. P.F. Adams, and M.A. Marano Current estimates from the national health survey, 1994 Vital Health Stat 10 1995 1 94
2. N. Pearce, J. Sunyer, S. Cheng, S. Chinn, B. Bjorksten, and M. Burr Comparison of asthma prevalence in the ISAAC and the ECRHS: ISAAC Steering Committee and the European Community Respiratory Health Survey. International Study of Asthma and Allergies in Childhood Eur Respir J 16 3 2000 420 426
3. J. Douwes, P. Gibson, J. Pekkanen, and N. Pearce Non-eosinophilic asthma: importance and possible mechanisms Thorax 57 7 2002 643 648
4. S.T. Holgate The cellular and mediator basis of asthma in relation to natural history Lancet 350 Suppl 2 1997 SII5 SII9
5. J.L. Bodmer, P. Schneider, and J. Tschopp The molecular architecture of the TNF superfamily Trends Biochem Sci 27 1 2002 19 26
6. K.J. Tracey, and A. Cerami Tumor necrosis factor: an updated review of its biology Crit Care Med 21 10 Suppl 1993 S415 S422
7. L.A. Tartaglia, R.F. Weber, I.S. Figari, C. Reynolds, M.A. Palladino Jr, and D.V. Goeddel The two different receptors for tumor necrosis factor mediate distinct cellular responses Proc Natl Acad Sci U S A 88 20 1991 9292 9296
8. H. Wajant, F. Henkler, and P. Scheurich The TNF-receptor-associated factor family: scaffold molecules for cytokine receptors, kinases and their regulators Cell Signal 13 6 2001 389 400
9. W.R. Coward, Y. Okayama, H. Sagara, S.J. Wilson, S.T. Holgate, and M.K. Church NF-kappaB and TNF-alpha: a positive autocrine loop in human lung mast cells? J Immunol 169 9 2002 5287 5293
10. P. Bradding, J.A. Roberts, K.M. Britten, S. Montefort, R. Djukanovic, and R. Mueller Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines Am J Respir Cell Mol Biol 10 5 1994 471 480
11. P.S. Thomas Tumour necrosis factor-alpha: the role of this multifunctional cytokine in asthma Immunol Cell Biol 79 2 2001 132 140
12. P. Bradding, Y. Okayama, P.H. Howarth, M.K. Church, and S.T. Holgate Heterogenicity of human mast cells based on cytokine content J Immunol 155 1995 297 307
13. P. Bradding, R. Mediwake, I.H. Feather, J. Madden, M.K. Church, and S.T. Holgate TNF alpha is localized to nasal mucosal mast cells and is released in acute allergic rhinitis Clin Exp Allergy 25 5 1995 406 415
14. J.R. Gordon, and S.J. Galli Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin Nature 346 6281 1990 274 276
15. J.R. Gordon, and S.J. Galli Release of both preformed and newly synthesized tumor necrosis factor alpha (TNF-alpha)/cachectin by mouse mast cells stimulated via the Fc epsilon RI: a mechanism for the sustained action of mast cell-derived TNF-alpha during IgE-dependent biological responses J Exp Med 174 1 1991 103 107
16. J.J. Costa, K. Matossian, M.B. Resnick, W.J. Beil, D.T. Wong, and J.R. Gordon Human eosinophils can express the cytokines tumor necrosis factor-alpha and macrophage inflammatory protein-1 alpha J Clin Invest 91 6 1993 2673 2684
17. S. Finotto, I. Ohno, J.S. Marshall, J. Gauldie, J.A. Denburg, and J. Dolovich TNF-alpha production by eosinophils in upper airways inflammation (nasal polyposis) J Immunol 153 5 1994 2278 2289
18. O.A. Khair, J.L. Devalia, M.M. Abdelaziz, R.J. Sapsford, H. Tarraf, and R.J. Davies Effect of Haemophilus influenzae endotoxin on the synthesis of IL-6, IL-8, TNF-alpha and expression of ICAM-1 in cultured human bronchial epithelial cells Eur Respir J 7 12 1994 2109 2116
19. H. Yamamoto, J.B. Sedgwick, and W.W. Busse Differential regulation of eosinophil adhesion and transmigration by pulmonary microvascular endothelial cells J Immunol 161 2 1998 971 977
20. P. Lassalle, P. Gosset, Y. Delneste, A. Tsicopoulos, A. Capron, and M. Joseph Modulation of adhesion molecule expression on endothelial cells during the late asthmatic reaction: role of macrophage-derived tumour necrosis factor-alpha Clin Exp Immunol 94 1 1993 105 110
21. V. Godding, J.M. Stark, J.B. Sedgwick, and W.W. Busse Adhesion of activated eosinophils to respiratory epithelial cells is enhanced by tumor necrosis factor-alpha and interleukin-1 beta Am J Respir Cell Mol Biol 13 5 1995 555 562
22. R.A. Panettieri Jr, A.L. Lazaar, E. Pure, and S.M. Albelda Activation of cAMP-dependent pathways in human airway smooth muscle cells inhibits TNF-alpha-induced ICAM-1 and VCAM-1 expression and T lymphocyte adhesion J Immunol 154 5 1995 2358 2365
23. J.C. Kips, J. Tavernier, and R.A. Pauwels Tumor necrosis factor causes bronchial hyperresponsiveness in rats Am Rev Respir Dis 145 2 Pt 1 1992 332 336
24. M.P. Hallsworth, C.P. Soh, S.J. Lane, J.P. Arm, and T.H. Lee Selective enhancement of GM-CSF, TNF-alpha, IL-1 beta and IL-8 production by monocytes and macrophages of asthmatic subjects Eur Respir J 7 6 1994 1096 1102
25. M. Cembrzynska-Nowak, E. Szklarz, A.D. Inglot, and J.A. Teodorczyk-Injeyan Elevated release of tumor necrosis factor-alpha and interferon-gamma by bronchoalveolar leukocytes from patients with bronchial asthma Am Rev Respir Dis 147 2 1993 291 295
26. V.J. Palombella, J. Mendelsohn, and J. Vilcek Mitogenic action of tumor necrosis factor in human fibroblasts: interaction with epidermal growth factor and platelet-derived growth factor J Cell Physiol 135 1 1988 23 31
27. A. Schwingshackl, M. Duszyk, N. Brown, and R. Moqbel Human eosinophils release matrix metalloproteinase-9 on stimulation with TNF-alpha J Allergy Clin Immunol 104 5 1999 983 989
28. S.J. Levine, P. Larivee, C. Logun, C.W. Angus, F.P. Ognibene, and J.H. Shelhamer Tumor necrosis factor-alpha induces mucin hypersecretion and MUC-2 gene expression by human airway epithelial cells Am J Respir Cell Mol Biol 12 2 1995 196 204
29. M. Pellegrino, B. Minervini, P. Musto, R. Matera, A. Greco, and C. Checchia de Ambrosio Tumor necrosis factor-alpha and interleukin-1 beta: two possible mediators of allergic inflammation Minerva Pediatr 48 7-8 1996 309 312
30. S. Ying, D.S. Robinson, V. Varney, Q. Meng, A. Tsicopoulos, and R. Moqbel TNF alpha mRNA expression in allergic inflammation Clin Exp Allergy 21 6 1991 745 750
31. P. Gosset, A. Tsicopoulos, B. Wallaert, M. Joseph, A. Capron, and A.B. Tonnel Tumor necrosis factor alpha and interleukin-6 production by human mononuclear phagocytes from allergic asthmatics after IgE-dependent stimulation Am Rev Respir Dis 146 3 1992 768 774
32. V.M. Keatings, B.J. O'Connor, L.G. Wright, D.P. Huston, C.J. Corrigan, and P.J. Barnes Late response to allergen is associated with increased concentrations of tumor necrosis factor-alpha and IL-5 in induced sputum J Allergy Clin Immunol 99 5 1997 693 698
33. European Network for Understanding Mechanisms of Severe Asthma The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma Eur Respir J 22 2003 470 477
34. T. Kobayashi, S. Hashimoto, K. Imai, E. Amemiya, M. Yamaguchi, and A. Yachi Elevation of serum soluble intercellular adhesion molecule-1 (sICAM-1) and sE-selectin levels in bronchial asthma Clin Exp Immunol 96 1 1994 110 115
35. A. Koizumi, S. Hashimoto, T. Kobayashi, K. Imai, A. Yachi, and T. Horie Elevation of serum soluble vascular cell adhesion molecule-1 (sVCAM-1) levels in bronchial asthma Clin Exp Immunol 101 3 1995 468 473
36. S. Kwon, and S.C. George Synergistic cytokine-induced nitric oxide production in human alveolar epithelial cells Nitric Oxide 3 4 1999 348 357
37. S.R. Johnson, and A.J. Knox Synthetic functions of airway smooth muscle in asthma Trends Pharmacol Sci 18 8 1997 288 292
38. S.Z. Anticevich, J.M. Hughes, J.L. Black, and C.L. Armour Induction of human airway hyperresponsiveness by tumour necrosis factor- alpha Eur J Pharmacol 284 1â€"2 1995 221 225
39. P.S. Thomas, D.H. Yates, and P.J. Barnes Tumor necrosis factor-alpha increases airway responsiveness and sputum neutrophilia in normal human subjects Am J Respir Crit Care Med 152 1 1995 76 80
40. M.B. Sukkar, J.M. Hughes, C.L. Armour, and P.R. Johnson Tumour necrosis factor-alpha potentiates contraction of human bronchus in vitro Respirology 6 3 2001 199 203
41. Y. Amrani, H. Chen, and R.A. Panettieri Jr Activation of tumor necrosis factor receptor 1 in airway smooth muscle: a potential pathway that modulates bronchial hyper-responsiveness in asthma? Respir Res 1 1 2000 49 53
42. M.F. Wilkinson, M.L. Earle, C.R. Triggle, and S. Barnes Interleukin-1beta, tumor necrosis factor-alpha, and LPS enhance calcium channel current in isolated vascular smooth muscle cells of rat tail artery FASEB J 10 7 1996 785 791
43. Y. Amrani, and R.A. Panettieri Jr Cytokines induce airway smooth muscle cell hyperresponsiveness to contractile agonists Thorax 53 8 1998 713 716
44. Holgate S. Clinical, physiological and inflammatory features of chronic severe asthma: a multicentre European study. European Network for Understanding Mechanisms of Severe Asthma; 2002
45. A. Chetta, A. Foresi, M. Del Donno, G. Bertorelli, A. Pesci, and D. Olivieri Airways remodeling is a distinctive feature of asthma and is related to severity of disease Chest 111 4 1997 852 857
46. R. Beasley, W.R. Roche, J.A. Roberts, and S.T. Holgate Cellular events in the bronchi in mild asthma and after bronchial provocation Am Rev Respir Dis 139 3 1989 806 817
47. H.W. Chu, J.L. Halliday, R.J. Martin, D.Y. Leung, S.J. Szefler, and S.E. Wenzel Collagen deposition in large airways may not differentiate severe asthma from milder forms of the disease Am J Respir Crit Care Med 158 6 1998 1936 1944
48. L. Benayoun, A. Druilhe, M.C. Dombret, M. Aubier, and M. Pretolani Airway structural alterations selectively associated with severe asthma Am J Respir Crit Care Med 167 10 2003 1360 1368
49. N. Carroll, J. Elliot, A. Morton, and A. James The structure of large and small airways in nonfatal and fatal asthma Am Rev Respir Dis 147 2 1993 405 410
50. S.E. Wenzel, S.J. Szefler, D.Y. Leung, S.I. Sloan, M.D. Rex, and R.J. Martin Bronchoscopic evaluation of severe asthma: persistent inflammation associated with high dose glucocorticoids Am J Respir Crit Care Med 156 3 Pt 1 1997 737 743
51. S.E. Wenzel The significance of neutrophils in asthma Clin Exp Allergy Rev 1 2 2001 89 92
52. M.A. Cassatella The production of cytokines by polymorphonuclear neutrophils Immunol Today 16 1 1995 21 26
53. S. Meltzer, B. Goldberg, P. Lad, and J. Easton Superoxide generation and its modulation by adenosine in the neutrophils of subjects with asthma J Allergy Clin Immunol 83 5 1989 960 966
54. A.M. Vignola, A. Bonanno, A. Mirabella, L. Riccobono, F. Mirabella, and M. Profita Increased levels of elastase and alpha1-antitrypsin in sputum of asthmatic patients Am J Respir Crit Care Med 157 2 1998 505 511
55. A.P. Sampson The role of eosinophils and neutrophils in inflammation Clin Exp Allergy 30 Suppl 1 2000 22 27
56. A. Druilhe, S. Letuve, and M. Pretolani Glucocorticoid-induced apoptosis in human eosinophils: mechanisms of action Apoptosis 8 5 2003 481 495
57. A. Desmouliere, A. Geinoz, F. Gabbiani, and G. Gabbiani Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts J Cell Biol 122 1 1993 103 111
58. E.M. Minshall, D.Y. Leung, R.J. Martin, Y.L. Song, L. Cameron, and P. Ernst Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma Am J Respir Cell Mol Biol 17 3 1997 326 333
59. A. Jatakanon, C. Uasuf, W. Maziak, S. Lim, K.F. Chung, and P.J. Barnes Neutrophilic inflammation in severe persistent asthma Am J Respir Crit Care Med 160 5 Pt 1 1999 1532 1539
60. O. Michel, J. Kips, J. Duchateau, F. Vertongen, L. Robert, and H. Collet Severity of asthma is related to endotoxin in house dust Am J Respir Crit Care Med 154 6 Pt 1 1996 1641 1646
61. I. Tillie-Leblond, J. Pugin, C.H. Marquette, C. Lamblin, F. Saulnier, and A. Brichet Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus Am J Respir Crit Care Med 159 2 1999 487 494
62. J.C. Webster, R.H. Oakley, C.M. Jewell, and J.A. Cidlowski Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative beta isoform: a mechanism for the generation of glucocorticoid resistance Proc Natl Acad Sci U S A 98 12 2001 6865 6870
63. T. Naseer, E.M. Minshall, D.Y. Leung, S. Laberge, P. Ernst, and R.J. Martin Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy Am J Respir Crit Care Med 155 3 1997 845 851
64. H.M. Lorenz, and J.R. Kalden Perspectives for TNF-alpha-targeting therapies Arthritis Res 4 Suppl 3 2002 S17 S24
65. D.J. Lovell, E.H. Giannini, A. Reiff, G.D. Cawkwell, E.D. Silverman, and J.J. Nocton Etanercept in children with polyarticular juvenile rheumatoid arthritis: Pediatric Rheumatology Collaborative Study Group N Engl J Med 342 11 2000 763 769
66. D.H. Present, P. Rutgeerts, S. Targan, S.B. Hanauer, L. Mayer, and R.A. van Hogezand Infliximab for the treatment of fistulas in patients with Crohn's disease N Engl J Med 340 18 1999 1398 1405
67. U. Chaudhari, P. Romano, L.D. Mulcahy, L.T. Dooley, D.G. Baker, and A.B. Gottlieb Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial Lancet 357 9271 2001 1842 1847
68. P.J. Mease, B.S. Goffe, J. Metz, A. VanderStoep, B. Finck, and D.J. Burge Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial Lancet 356 9227 2000 385 390
69. G. D'Haens, S. Van Deventer, R. Van Hogezand, D. Chalmers, C. Kothe, and F. Baert Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: a European multicenter trial Gastroenterology 116 5 1999 1029 1034
70. J.C. Shanahan, and W. St Clair Tumor necrosis factor-alpha blockade: a novel therapy for rheumatic disease Clin Immunol 103 3 Pt 1 2002 231 242
71. P.P. Tak, P.C. Taylor, F.C. Breedveld, T.J. Smeets, M.R. Daha, and P.M. Kluin Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis Arthritis Rheum 39 7 1996 1077 1081
72. M.J. Elliott, R.N. Maini, M. Feldmann, A. Long-Fox, P. Charles, and P. Katsikis Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha Arthritis Rheum 36 12 1993 1681 1690
73. F.M. Brennan, K.A. Browne, P.A. Green, J.M. Jaspar, R.N. Maini, and M. Feldmann Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti-tumour necrosis factor-alpha (cA2) therapy Br J Rheumatol 36 6 1997 643 650
74. E.M. Paleolog, S. Young, A.C. Stark, R.V. McCloskey, M. Feldmann, and R.N. Maini Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis Arthritis Rheum 41 7 1998 1258 1265
75. P. Lipsky, W. St Clair, D. Frust, F.C. Breedveld, J.S. Smolen, and J.R. Kalden 54 week clinical and radiographic results from the attract trial: a phase III study of infliximab (Remicadeâ.,¢) in patients with active RA despite methotrexate Arthritis Rheum 42 1999 S401
76. L.W. Moreland, S.W. Baumgartner, M.H. Schiff, E.A. Tindall, R.M. Fleischmann, and A.L. Weaver Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein N Engl J Med 337 3 1997 141 147
77. J.D. Gorman, K.E. Sack, and J.C. Davis Jr Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha N Engl J Med 346 18 2002 1349 1356
78. E. Cauza, M. Spak, K. Cauza, U. Hanusch-Enserer, A. Dunky, and E. Wagner Treatment of psoriatic arthritis and psoriasis vulgaris with the tumor necrosis factor inhibitor infliximab Rheumatol Int 22 6 2002 227 232
79. J. Braun, J. Brandt, J. Listing, A. Zink, R. Alten, and W. Golder Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial Lancet 359 9313 2002 1187 1193
80. P.P. Sfikakis Behcet's disease: a new target for anti-tumour necrosis factor treatment Ann Rheum Dis 61 Suppl 2 2002 ii51 ii53
81. R.P. Baughman, E.E. Lower, and R.M. du Bois Sarcoidosis Lancet 361 9363 2003 1111 1118
82. H. Engelmann, D. Aderka, M. Rubinstein, D. Rotman, and D. Wallach A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity J Biol Chem 264 20 1989 11974 11980
83. P. Seckinger, S. Isaaz, and J.M. Dayer A human inhibitor of tumor necrosis factor alpha J Exp Med 167 4 1988 1511 1516
84. K.M. Mohler, D.S. Torrance, C.A. Smith, R.G. Goodwin, K.E. Stremler, and V.P. Fung Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists J Immunol 151 3 1993 1548 1561
85. L.W. Moreland, G. Margolies, L.W. Heck Jr, A. Saway, C. Blosch, and R. Hanna Recombinant soluble tumor necrosis factor receptor (p80) fusion protein: toxicity and dose finding trial in refractory rheumatoid arthritis J Rheumatol 23 11 1996 1849 1855
86. K.S. Babu, S. Puddicombe, T.J. Shaw, T. Howell, S.J. Wilson, and S.T. Holgate Effects of blocking tumour necrosis factor alpha on responses of bronchial explants from subjects with moderately severe asthma Am J Respir Crit Care Med 169 2004 A801
87. K.S. Babu, S.H. Arshad, P.H. Howarth, A.J. Chauhan, E.J. Bell, and S.M. Puddicombe Tumor necrosis factor alpha (TNF-alpha) as an effective therapeutic strategy in chronic severe asthma J Allergy Clin Immunol 111 2003 S277
88. M. Feldmann, and R.N. Maini Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? Annu Rev Immunol 19 2001 163 196